These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19156121)

  • 21. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of deep brain stimulation in our patients with Parkinson's disease].
    Tamás G; Takáts A; Radics P; Rózsa I; Csibri E; Rudas G; Golopencza P; Entz L; Fabó D; Eross L
    Ideggyogy Sz; 2013 Mar; 66(3-4):115-20. PubMed ID: 23750427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate versus delayed switch from levodopa/carbidopa to levodopa/carbidopa/entacapone: effects on motor function and quality of life in patients with Parkinson's disease with end-of-dose wearing off.
    Lew MF; Somogyi M; McCague K; Welsh M;
    Int J Neurosci; 2011 Nov; 121(11):605-13. PubMed ID: 21843110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label, flexible-dose study of memantine in major depressive disorder.
    Ferguson JM; Shingleton RN
    Clin Neuropharmacol; 2007; 30(3):136-44. PubMed ID: 17545748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.
    Vidal EI; Fukushima FB; Valle AP; Villas Boas PJ
    J Am Geriatr Soc; 2013 Jan; 61(1):170-2. PubMed ID: 23311565
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease.
    Tolosa E; Stern MB
    Eur J Neurol; 2012 Feb; 19(2):258-64. PubMed ID: 21819487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial.
    Schulz JB; Rainer M; Klünemann HH; Kurz A; Wolf S; Sternberg K; Tennigkeit F
    J Alzheimers Dis; 2011; 25(3):463-75. PubMed ID: 21471647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.
    Rascol O; Barone P; Hauser RA; Mizuno Y; Poewe W; Schapira AH; Salin L; Sohr M; Debieuvre C;
    Mov Disord; 2010 Oct; 25(14):2326-32. PubMed ID: 20669265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease.
    Jones RW; Bayer A; Inglis F; Barker A; Phul R
    Int J Geriatr Psychiatry; 2007 Mar; 22(3):258-62. PubMed ID: 17243195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine deficiency may lead to capgras syndrome in Parkinson's disease with dementia.
    Shiotsuki H; Motoi Y; Nakamura S; Mizuno Y; Hattori N
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352i.e14-352.e15. PubMed ID: 20686153
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
    Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
    Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial.
    Kieburtz K;
    Mov Disord; 2011 Jan; 26(1):37-44. PubMed ID: 20925067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies.
    Wesnes KA; Aarsland D; Ballard C; Londos E
    Int J Geriatr Psychiatry; 2015 Jan; 30(1):46-54. PubMed ID: 24737460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of memantine in Lewy body dementia.
    Levin OS; Batukaeva LA; Smolentseva IG; Amosova NA
    Neurosci Behav Physiol; 2009 Jul; 39(6):597-604. PubMed ID: 19517247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.
    Ziegler M; Castro-Caldas A; Del Signore S; Rascol O
    Mov Disord; 2003 Apr; 18(4):418-25. PubMed ID: 12671949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.